In an interaction with Kshitij Anand of ETMarkets, Saurabh Prasad, Head – Research Centre at Mirae Asset Sharekhan, said large caps are now...

Tyagi, however, remains cautious on pockets of the mid- and small-cap universe, where valuations are above long-term averages. He sees larg...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

India sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...

For the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...

Biocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...

For the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...

Indian stock markets experienced a range-bound week with minor losses for Sensex and Nifty. Analysts are watching four key factors that wil...

Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalido...

Independence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...

During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...

Jubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...

Sustained market demand led to impressive revenue growth in the automotive and consumer goods sectors. In contrast, while the banking secto...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

European stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...

Dermatologists report increased hair loss among GLP-1 drug users experiencing rapid weight reduction. This side effect, often telogen efflu...